Project Number GC-2013179 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2016 View Full Project Details for Selective Cyclophilin D inhibitors for neurodegeneration Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) h. Cell death Researcher and Organization Principal Investigator Peel, Michael Principal Investigator First Name Michael Principal Investigator Last Name Peel Awardee Organization Cypralis Ltd Contact PI Country England Project Detail Funding Opportunity Announcement Preclinical RFP FY Overall Cost $523,940 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States
